Real-world efficacy of sequential nivolumab for metastatic renal cancer after first-line molecular targeting therapy.
Medicine (Baltimore)
; 101(32): e29510, 2022 Aug 12.
Article
in En
| MEDLINE
| ID: mdl-35960101
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Antineoplastic Agents, Immunological
/
Kidney Neoplasms
Type of study:
Guideline
/
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Medicine (Baltimore)
Year:
2022
Document type:
Article
Affiliation country:
Japón
Country of publication:
Estados Unidos